Quick Summary:
In the dynamic landscape of the pharmaceutical industry, understanding the active pharmaceutical ingredients (API) market has become increasingly salient for strategic decision-making. Our comprehensive report provides incisive insights into the global API market, helping you navigate shifting trends, and enabling you to position your business for future success.
The API market plays a crucial role in the overall pharmaceutical sector, representing the core ingredients that make therapeutic efficacy of a drug possible. Our study delves into vital categorizations – from drug types such as innovative and generic active ingredients, to different types of manufacturers and synthesis methods. Coupled with high-potency biological APIs and a rising demand for generic APIs due to significant patent expiries, the API market is set to experience considerable growth.
The report also dissects the market by therapeutic applications and regions, giving a detailed synopsis on trends and opportunities in areas such as oncology, cardiovascular and respiratory, and diabetes, across North America, Europe, Asia Pacific, and more. With a landscape as competitive as API manufacturing, be armed with knowledge on the positions and strategies of key players, and discover the factors catalyzing APIs' global demand.
Ignite your business strategy with our expert insights and detailed analysis. This market research report is an essential tool for those wishing to solidify their understanding and position in the API market. Let our findings guide your way to success in the burgeoning global API industry.
The global active pharmaceutical ingredients (API) market size reached US$ 222.9 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 303.9 Billion by 2028, exhibiting a growth rate (CAGR) of 5.6% during 2023-2028.
Active pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of a drug (e.g. tablet, capsule). A drug is usually composed of several components. The API represents the primary ingredient. Other ingredients are commonly known as excipients. Sometimes a drug can contain several APIs and its effect on a patient depends on the dosage prescribed and can vary from person to person. In combination therapies, two or more than two active ingredients are used to treat different symptoms in different ways. Stringent quality control is a mandate when it comes to the manufacturing of drugs as the API represents the main component considered while making the prescription.
Pharmaceutical manufacturing occurs in two general steps. In the first step, manufacturers convert raw materials into APIs. The second step involves creating the final formulation by mixing APIs and excipients into tablets, capsules, solutions, etc. and finally packaging the drug for the end users. Manufacturers either sell APIs in the open market (also known as the merchant market) or use them as inputs to make their final formulations. The global API market is extremely competitive with a number of large and small manufacturers. Firms that engage in API manufacturing generally specialize and target their manufacturing based on a combination of the firms in-house skills and market opportunities. Catalyzed by lower costs, API manufacturing has gradually been shifting from the historical leaders in Western countries to manufacturers based in India and China.
The global demand of APIs is currently exhibiting strong growth. One of the major drivers of this market is the rising number of blockbuster patent expiries creating a significant opportunity for generic APIs. Moreover, there has been a strong demand for APIs for biologicals. The global market for biologicals is currently exhibiting strong growth catalyzed by their high potency and ability to treat diseases beyond the scope of small molecule drugs. This is creating a strong demand for APIs for branded biological drugs and their biosimilar versions. Other factors catalyzing the global demand of APIs include ageing population, rising expenditures on healthcare, increasing prevalence of lifestyle diseases, etc.
2. What is the expected growth rate of the global Active Pharmaceutical Ingredients (API) market during 2023-2028?
3. What are active ingredients in pharmaceutical industry?
4. What are the key factors driving the global Active Pharmaceutical Ingredients (API) market?
5. What has been the impact of COVID-19 on the global Active Pharmaceutical Ingredients (API) market?
6. What is the breakup of the global Active Pharmaceutical Ingredients (API) market based on the drug type?
7. What is the breakup of the global Active Pharmaceutical Ingredients (API) market based on the type of manufacturer?
8. What is the breakup of the global Active Pharmaceutical Ingredients (API) market based on the type of synthesis?
9. What is the breakup of the global Active Pharmaceutical Ingredients (API) market based on the therapeutic application?
10. What are the key regions in the global Active Pharmaceutical Ingredients (API) market?
11. Who is the biggest API manufacturer?
12. Who are the key players/companies in the global Active Pharmaceutical Ingredients (API) market?
Active pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of a drug (e.g. tablet, capsule). A drug is usually composed of several components. The API represents the primary ingredient. Other ingredients are commonly known as excipients. Sometimes a drug can contain several APIs and its effect on a patient depends on the dosage prescribed and can vary from person to person. In combination therapies, two or more than two active ingredients are used to treat different symptoms in different ways. Stringent quality control is a mandate when it comes to the manufacturing of drugs as the API represents the main component considered while making the prescription.
Pharmaceutical manufacturing occurs in two general steps. In the first step, manufacturers convert raw materials into APIs. The second step involves creating the final formulation by mixing APIs and excipients into tablets, capsules, solutions, etc. and finally packaging the drug for the end users. Manufacturers either sell APIs in the open market (also known as the merchant market) or use them as inputs to make their final formulations. The global API market is extremely competitive with a number of large and small manufacturers. Firms that engage in API manufacturing generally specialize and target their manufacturing based on a combination of the firms in-house skills and market opportunities. Catalyzed by lower costs, API manufacturing has gradually been shifting from the historical leaders in Western countries to manufacturers based in India and China.
The global demand of APIs is currently exhibiting strong growth. One of the major drivers of this market is the rising number of blockbuster patent expiries creating a significant opportunity for generic APIs. Moreover, there has been a strong demand for APIs for biologicals. The global market for biologicals is currently exhibiting strong growth catalyzed by their high potency and ability to treat diseases beyond the scope of small molecule drugs. This is creating a strong demand for APIs for branded biological drugs and their biosimilar versions. Other factors catalyzing the global demand of APIs include ageing population, rising expenditures on healthcare, increasing prevalence of lifestyle diseases, etc.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global active pharmaceutical ingredients (API) market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug type, type of manufacturer, type of synthesis and therapeutic application.Breakup by Drug Type:
- Innovative Active Pharmaceutical Ingredients (API)
- Generic Active Pharmaceutical Ingredients (API)
Breakup by Type of Manufacturer:
- Captive Manufacturers
- Merchant API Manufacturers
- Innovative Merchant API Manufacturers
- Generic Merchant API Manufacturers
Breakup by Type of Synthesis:
- Synthetic Active Pharmaceutical Ingredients (API)
Market Breakup by Type
- Innovative Synthetic APIs
- Generic Synthetic APIs
- Biotech Active Pharmaceutical Ingredients (API)
Market Breakup by Type
- Innovative Biotech APIs
- Biosimilars
Market Breakup By Product
- Monoclonal Antibodies
- Vaccines
- Cytokines
- Fusion Proteins
- Therapeutic Enzymes
- Blood Factors
Market Breakup By Expression System
- Mammalian Expression Systems
- Microbial Expression Systems
- Yeast Expression Systems
- Transgenic Animal Systems
- Others
Breakup by Therapeutic Application:
- Oncology
- Cardiovascular and Respiratory
- Diabetes
- Central Nervous System Disorders
- Neurological Disorders
- Others
Breakup by Region:
North America
- United States
- Canada
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Latin America
Middle East and Africa
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.Competitive Landscape:
The competitive landscape of the market has also been examined with some of the (active pharmaceutical ingredients companies) key players being Pfizer, Inc., Novartis International AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceutical Industries Ltd., ELI Lilly and Company, GlaxoSmithKline, Merck & Co., Inc. and Abbvie Inc.Key Questions Answered in This Report
1. How big is the active pharmaceutical ingredient market?2. What is the expected growth rate of the global Active Pharmaceutical Ingredients (API) market during 2023-2028?
3. What are active ingredients in pharmaceutical industry?
4. What are the key factors driving the global Active Pharmaceutical Ingredients (API) market?
5. What has been the impact of COVID-19 on the global Active Pharmaceutical Ingredients (API) market?
6. What is the breakup of the global Active Pharmaceutical Ingredients (API) market based on the drug type?
7. What is the breakup of the global Active Pharmaceutical Ingredients (API) market based on the type of manufacturer?
8. What is the breakup of the global Active Pharmaceutical Ingredients (API) market based on the type of synthesis?
9. What is the breakup of the global Active Pharmaceutical Ingredients (API) market based on the therapeutic application?
10. What are the key regions in the global Active Pharmaceutical Ingredients (API) market?
11. Who is the biggest API manufacturer?
12. Who are the key players/companies in the global Active Pharmaceutical Ingredients (API) market?
Frequently Asked Questions about the Global Active Pharmaceutical Ingredients (API) Market
What is the estimated value of the Global Active Pharmaceutical Ingredients (API) Market?
What is the growth rate of the Global Active Pharmaceutical Ingredients (API) Market?
What is the forecasted size of the Global Active Pharmaceutical Ingredients (API) Market?
Who are the key companies in the Global Active Pharmaceutical Ingredients (API) Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 138 |
| Published | May 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 222.9 Billion |
| Forecasted Market Value ( USD | $ 303.9 Billion |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
Table of Contents
1 Preface3 Executive Summary
2 Scope and Methodology
4 Introduction
5 Global Active Pharmaceutical Ingredients (API) Market
6 Market Breakup by Drug Type
7 Market Breakup by Type of Manufacturer
8 Market Breakup by Type of Synthesis
9 Market Breakup by Therapeutic Application
10 Market Breakup by Region
11 API Manufacturing Process
12 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Pfizer Inc.
- Novartis International AG
- Sanofi
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Teva Pharmaceutical Industries Ltd.
- ELI Lilly and Company
- GlaxoSmithKline
- Merck & Co. Inc.
- Abbvie Inc.
Methodology
LOADING...
